Insider Trading History of Goel David E.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Goel David E. since 2021. This trader's CIK number is 1548144. At the time of last reporting, Goel David E. was the Officer of Zentalis Pharmaceuticals, Inc.. (stock ticker symbol ZNTL). Also see all insider trading activities at Zentalis Pharmaceuticals, Inc..

Note that in the past GOEL DAVID E. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Zentalis Pharmaceuticals, Inc. (ZNTL) by Goel David E.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 ZNTL 0 $0 7,500,000 $9,975,000 0 $0
2023 ZNTL 4,760,000 $107,861,600 0 $0 0 $0

Yearly summary of insider trading at Aura Biosciences, Inc. (AURA) by Goel David E.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 AURA 1,560,000 $14,040,000 0 $0 0 $0
2021 AURA 1,785,000 $24,990,000 0 $0 0 $0


Insider trading activities at 2 companies by Goel David E.:

1. Zentalis Pharmaceuticals, Inc. (ZNTL)

2. Aura Biosciences, Inc. (AURA)

Table 1. Insider trading of Zentalis Pharmaceuticals, Inc. (ZNTL) by Goel David E.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-12-15 ZNTL Sale 7,500,000 1.33 9,975,000
2023-06-20 ZNTL Buy 4,760,000 22.66 107,861,600

Table 2. Insider trading of Aura Biosciences, Inc. (AURA) by Goel David E.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-11-09 AURA Buy 1,560,000 9.00 14,040,000
2021-11-02 AURA Buy 1,785,000 14.00 24,990,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Goel David E. (Officer of Zentalis Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.